04,585) 2,876,980 129,436 9,828,100
OTHER INCOME (EXPENSE):
Earnings on
equity investment 59,524 43,070 92,936 192,826
Other income 60,364 67,451 115,545 177,160
Other expense (4,428) (96,191) (255,540) (300,035)
Interest expense
and other charges (527,987) (738,634) (591,493) (1,674,515)
Interest income 7,548 55,697 104,221 154,101
Other expense,
net (404,979) (668,607) (534,331) (1,450,463)
(LOSS) INCOME BEFORE
PROVISION FOR INCOME
TAXES (709,564) 2,208,373 (404,895) 8,377,637
PROVISION FOR
INCOME TAXES (48,166) 321,220 100,594 1,108,388
NET (LOSS) INCOME (661,398) 1,887,153 (505,489) 7,269,249
OTHER COMPREHENSIVE
INCOME:
Foreign
currency
translation
adjustments (60,568) 1,554,258 227,158 2,966,909
COMPREHENSIVE
(LOSS) INCOME $ (721,966)$ 3,441,411 $ (278,331)$ 10,236,158
(LOSS) EARNINGS
PER SHARE
Basic $ (0.03)$ 0.10 $ (0.03)$ 0.38
Diluted $ (0.03)$ 0.10 $ (0.03)$ 0.36
WEIGHTED AVERAGE
NUMBER OF SHARES
Basic 19,169,805 19,069,805 19,129,146 18,967,857
Diluted 19,169,805 19,845,195 19,129,146 19,959,689
Shengtai Pharmaceutical, Inc.
Consolidated Statements of Cash Flows
For the nine months ended March 31, 2009 and 2008
(Unaudited)
2009 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
'/>"/>SOURCE Shengtai Pharmaceutical, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine news :1.
Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call2.
Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference3.
Shengtai Pharmaceutical, Inc. Comments On Its Operations4.
Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call5.
Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan6.
Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference7.
Shengtai Pharmaceutical Expands International Sales Program8.
Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 20089.
Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 200810.
Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 200811.
Shengtai Pharmaceutical, Inc. to Present at Roth Conference